CRIS Current Research Information System

ULIVI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.606
NA - Nord America 1.014
EU - Europa 989
SA - Sud America 174
AF - Africa 108
OC - Oceania 5
Totale 4.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 986
CN - Cina 878
SG - Singapore 844
VN - Vietnam 310
DE - Germania 251
IT - Italia 225
KR - Corea 217
HK - Hong Kong 186
BR - Brasile 128
NL - Olanda 128
SE - Svezia 102
GB - Regno Unito 76
IN - India 74
CI - Costa d'Avorio 50
FR - Francia 42
FI - Finlandia 39
JP - Giappone 33
IE - Irlanda 32
RU - Federazione Russa 27
ID - Indonesia 24
AR - Argentina 23
SC - Seychelles 20
BG - Bulgaria 19
MX - Messico 13
TG - Togo 13
AT - Austria 12
JO - Giordania 11
UA - Ucraina 11
CA - Canada 10
BE - Belgio 7
ZA - Sudafrica 7
CO - Colombia 6
EC - Ecuador 6
TR - Turchia 5
AU - Australia 4
BD - Bangladesh 4
CH - Svizzera 4
MA - Marocco 4
PL - Polonia 4
PY - Paraguay 4
UZ - Uzbekistan 4
PE - Perù 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
IQ - Iraq 2
KE - Kenya 2
LT - Lituania 2
NG - Nigeria 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
ZM - Zambia 1
Totale 4.896
Salva come PNG Salva come JPEG
Città #
Singapore 639
Hefei 531
Ashburn 219
Seoul 217
Hong Kong 186
Ho Chi Minh City 96
Amsterdam 67
Dallas 65
Hanoi 60
Fairfield 56
Santa Clara 55
Beijing 53
Chandler 51
Abidjan 50
Bengaluru 46
Southend 45
Krefeld 41
Los Angeles 38
Tokyo 33
Dublin 32
Bologna 31
Boardman 30
Dong Ket 28
Milan 28
Munich 26
Wilmington 26
Woodbridge 24
Princeton 23
Seattle 23
Rome 21
Ann Arbor 19
Jakarta 19
Sofia 19
Tongling 18
Redondo Beach 17
Helsinki 16
Houston 16
Bad Bellingen 15
Buffalo 15
Frankfurt am Main 15
Lappeenranta 15
Cambridge 14
Chicago 14
Lomé 13
Potenza 13
Amman 11
São Paulo 11
Falkenstein 10
Mexico City 10
Nuremberg 10
Da Nang 9
Guangzhou 9
Vienna 9
Council Bluffs 8
Düsseldorf 8
New York 8
Turku 8
Berlin 7
Can Tho 7
Cesena 7
Ha Long 7
Haiphong 7
Salt Lake City 7
Biên Hòa 6
Jacksonville 6
Nanjing 6
Redmond 6
The Dalles 6
Elk Grove Village 5
Naples 5
Nha Trang 5
Rancho Palos Verdes 5
San Diego 5
Stockholm 5
Tampa 5
Tianjin 5
Westminster 5
Brussels 4
Bắc Ninh 4
Denver 4
Faenza 4
Florence 4
Forlì 4
Guayaquil 4
Jinan 4
Johannesburg 4
Lauterbourg 4
London 4
Lucca 4
Quận Bình Thạnh 4
Rimini 4
Rio de Janeiro 4
San Francisco 4
San Lazzaro di Savena 4
Teggiano 4
Turin 4
Vũng Tàu 4
Barranquilla 3
Belo Horizonte 3
Bern 3
Totale 3.395
Salva come PNG Salva come JPEG
Nome #
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer 257
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 249
Schedule-dependent cytotoxic interaction between Epidoxorubicin and Gemcitabine in human bladder cancer cells in vitro. 211
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 198
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 167
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 137
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 133
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer 133
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 133
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 129
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 125
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation 120
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 119
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 116
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 114
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 111
Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials. 107
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities 107
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 107
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 104
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? 104
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 104
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 103
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 102
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 101
Genetic and epigenetic alterations of cdh1 regulatory regions in hereditary and sporadic gastric cancer 101
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress 100
Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis 100
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab 99
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 96
Genomic events stratifying prognosis of early gastric cancer 96
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer 95
Moving beyond parp inhibition: Current state and future perspectives in breast cancer 92
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 89
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 89
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 87
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 86
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer 82
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 79
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients 66
The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration 66
New generation anaplastic lymphoma kinase inhibitors 65
Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report. 57
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer 43
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer 41
Targeting RET-rearranged non-small-cell lung cancer: future prospects 13
Totale 5.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 3 1 9 13 2 22 54
2021/2022246 5 0 16 24 18 6 4 31 7 17 80 38
2022/2023283 17 42 17 27 18 27 4 21 63 4 22 21
2023/2024311 7 20 9 9 28 17 21 13 159 10 11 7
2024/20251.323 61 89 54 92 80 41 30 34 42 197 201 402
2025/20262.569 515 731 532 395 333 63 0 0 0 0 0 0
Totale 5.033